Concepts (54)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| MAP Kinase Signaling System | 2 | 2020 | 65 | 0.690 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2020 | 36 | 0.690 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2018 | 59 | 0.680 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2020 | 2 | 0.670 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2020 | 4 | 0.670 |
Why?
|
| Receptor, erbB-2 | 1 | 2020 | 65 | 0.650 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2020 | 88 | 0.640 |
Why?
|
| Breast Neoplasms | 3 | 2020 | 754 | 0.610 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2018 | 24 | 0.570 |
Why?
|
| DNA Damage | 1 | 2018 | 93 | 0.550 |
Why?
|
| Neoplastic Stem Cells | 2 | 2019 | 98 | 0.530 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 113 | 0.490 |
Why?
|
| MicroRNAs | 1 | 2018 | 188 | 0.480 |
Why?
|
| Lung Neoplasms | 2 | 2017 | 429 | 0.410 |
Why?
|
| Cell Line, Tumor | 4 | 2020 | 727 | 0.410 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2020 | 265 | 0.400 |
Why?
|
| Mice | 5 | 2020 | 2512 | 0.330 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2020 | 22 | 0.300 |
Why?
|
| Mice, Transgenic | 2 | 2020 | 258 | 0.290 |
Why?
|
| Neoplasm Metastasis | 2 | 2020 | 220 | 0.270 |
Why?
|
| Animals | 5 | 2020 | 7570 | 0.230 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2020 | 27 | 0.170 |
Why?
|
| Mammary Glands, Animal | 1 | 2020 | 64 | 0.160 |
Why?
|
| Breast | 1 | 2020 | 64 | 0.160 |
Why?
|
| Disease-Free Survival | 1 | 2020 | 326 | 0.160 |
Why?
|
| Epithelial Cells | 1 | 2020 | 129 | 0.160 |
Why?
|
| Cell Movement | 1 | 2020 | 172 | 0.160 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 1012 | 0.150 |
Why?
|
| Magnetic Field Therapy | 1 | 2019 | 17 | 0.150 |
Why?
|
| Calcium Channels, T-Type | 1 | 2019 | 29 | 0.150 |
Why?
|
| Myeloid Cells | 1 | 2019 | 39 | 0.150 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2017 | 18 | 0.130 |
Why?
|
| Protein Stability | 1 | 2017 | 26 | 0.130 |
Why?
|
| Calcium | 1 | 2019 | 323 | 0.130 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2017 | 15 | 0.130 |
Why?
|
| Enzyme Activation | 1 | 2017 | 133 | 0.130 |
Why?
|
| Liposomes | 1 | 2017 | 30 | 0.130 |
Why?
|
| Antibodies | 1 | 2017 | 51 | 0.130 |
Why?
|
| Phosphorylation | 1 | 2017 | 226 | 0.130 |
Why?
|
| Nanoparticles | 1 | 2017 | 56 | 0.120 |
Why?
|
| Humans | 5 | 2020 | 32814 | 0.110 |
Why?
|
| Brain Neoplasms | 1 | 2019 | 647 | 0.100 |
Why?
|
| Female | 2 | 2020 | 20271 | 0.060 |
Why?
|
| Male | 1 | 2017 | 19650 | 0.040 |
Why?
|
| HMGA2 Protein | 1 | 2019 | 13 | 0.040 |
Why?
|
| Electromagnetic Fields | 1 | 2019 | 28 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 316 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 497 | 0.030 |
Why?
|
| Models, Biological | 1 | 2019 | 392 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2019 | 603 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 169 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2019 | 687 | 0.030 |
Why?
|
| Lung | 1 | 2017 | 265 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2017 | 3441 | 0.020 |
Why?
|